Westlake Chemical Partners LP - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on March 29, 2019. Westlake Chemical Partners LP (the "Partnership") executed two significant capital transactions: the acquisition of additional equity in its operating subsidiary and a private placement of common units.
Key Financial Metrics and Transactions
- OpCo Equity Purchase: The Partnership purchased an additional 4.50% limited partner interest in Westlake Chemical OpCo LP ("OpCo") for approximately $201.4 million. This transaction increased the Partnership's fully diluted ownership in OpCo to approximately 22.8%.
- Private Placement: The Partnership issued and sold 2,940,818 Common Units in a private placement. The net proceeds from this placement were approximately $62.5 million.
- Funding Sources: The OpCo Equity Purchase was funded using the $62.5 million net proceeds from the Private Placement and borrowings under the Partnership's senior unsecured revolving credit agreement (the "MLP Revolver").
- Use of Proceeds: OpCo intends to use the proceeds from the equity purchase to repay borrowings under its intercompany debt agreements with Westlake Chemical Corporation.
Material Changes and Related Party Transactions
The transactions involve related parties, as Westlake Chemical Corporation ("Westlake") owns and controls the Partnership's General Partner and holds significant common units and incentive distribution rights. Key officers and directors, including Messrs. James Chao and Albert Chao, serve in leadership roles across Westlake, the General Partner, and other affiliated entities. The terms of the OpCo Equity Purchase were approved by the independent Conflicts Committee of the General Partner's Board of Directors, which engaged independent financial and legal advisors.
Guidance, Outlook, and Contingencies
The filing does not provide updated financial guidance or management commentary on future operational outlook. However, it outlines a specific contingency regarding the Private Placement:
- Registration Rights: The Partnership entered into a Registration Rights Agreement requiring the filing of a registration statement by April 26, 2019 to allow for the public resale of the unregistered Common Units sold to investors.
- Liquidated Damages: If the registration statement is not declared effective within 90 days (if subject to SEC review) or 10 days (if not subject to review) after filing, the Partnership will be required to pay liquidated damages as calculated in the agreement.
Investor Verification Checklist
- Verify the final ownership percentage of the Partnership in OpCo (stated as ~22.8% fully diluted) and the impact on future distribution rights.
- Confirm the status of the Registration Statement filing by the April 26, 2019 deadline to assess potential liquidated damages exposure.
- Review the Partnership's updated leverage ratios following the drawdown on the MLP Revolver to fund the OpCo purchase.
- Examine the related party transaction disclosures in the most recent Form 10-K to understand the full scope of control by Westlake Chemical Corporation.